Antibiotic Resistance and Virulence Mechanisms in Gram-Negative Bacteria: An Alliance for Success
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Mechanism and Evolution of Antibiotic Resistance".
Deadline for manuscript submissions: 1 May 2025 | Viewed by 2465
Special Issue Editor
Interests: Pseudomonas aeruginosa; Acinetobacter baumannii; gram-negative bacteria; polymyxins; antimetabolites; antivirulence drugs; outer membrane biogenesis; essential genes; iron uptake; lipopolysaccharide
Special Issue Information
Dear Colleagues,
Antimicrobial resistance (AMR) is one of the major challenges of this century. International organizations have been working to mitigate this phenomenon, and the first step in controlling it is to consider the issue within the One Health concept. In recent years, virulence has emerged as a growing threat in Gram-negative multi-drug-resistant pathogens. The association of AMR with virulence creates a perfect scenario for the success of these pathogens, whether by enabling their persistence in various environments or by making it difficult to achieve effective antibiotic treatment when they cause infections, among other factors. Therefore, it is important to assess the impact of this alliance within the One Health framework. The main focus of this Special Issue is AMR and virulence in Gram-negative bacteria across human and veterinary medicine, natural environments, the food industry, and agriculture.
Dr. Francesco Imperi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- virulence
- Gram-negative
- antimicrobial resistance
- One Health
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.